Adaptimmune Therapeutics Plc is a biopharmaceutical company focused on developing novel cell therapies for cancer patients. With operations in the US and UK, it's advancing treatments through clinical trials, including therapies for synovial sarcoma and ovarian cancer. The company collaborates with industry leaders like Genentech and F. Hoffman-La Roche to create both personalized and universal T-cell therapies. Founded in 2008 and based in Abingdon, UK, Adaptimmune also works closely with academic institutions and other biotech firms to innovate cancer treatment.